CY2204B1 - Angiotensin ii antagonists as a prophylactic or therapeutic drug for renal diseases - Google Patents

Angiotensin ii antagonists as a prophylactic or therapeutic drug for renal diseases

Info

Publication number
CY2204B1
CY2204B1 CY0000058A CY0000058A CY2204B1 CY 2204 B1 CY2204 B1 CY 2204B1 CY 0000058 A CY0000058 A CY 0000058A CY 0000058 A CY0000058 A CY 0000058A CY 2204 B1 CY2204 B1 CY 2204B1
Authority
CY
Cyprus
Prior art keywords
stands
prophylactic
therapeutic drug
angiotensin
antagonists
Prior art date
Application number
CY0000058A
Other languages
English (en)
Inventor
Kohei Nishikawa
Yumiko Shibouta
Keiji Kubo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CY2204B1 publication Critical patent/CY2204B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CY0000058A 1993-04-22 2000-12-08 Angiotensin ii antagonists as a prophylactic or therapeutic drug for renal diseases CY2204B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9594293 1993-04-22

Publications (1)

Publication Number Publication Date
CY2204B1 true CY2204B1 (en) 2002-11-08

Family

ID=14151326

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0000058A CY2204B1 (en) 1993-04-22 2000-12-08 Angiotensin ii antagonists as a prophylactic or therapeutic drug for renal diseases

Country Status (12)

Country Link
US (7) US5719173A (de)
EP (1) EP0622077B1 (de)
JP (1) JP3810020B2 (de)
AT (1) ATE194284T1 (de)
BR (1) BR1100756KB1 (de)
CA (1) CA2121871C (de)
CY (1) CY2204B1 (de)
DE (1) DE69425085T2 (de)
DK (1) DK0622077T3 (de)
ES (1) ES2149226T3 (de)
GR (1) GR3033862T3 (de)
PT (1) PT622077E (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003306432A (ja) * 1993-04-22 2003-10-28 Takeda Chem Ind Ltd 腎疾患の予防または治療剤
JP3810020B2 (ja) 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
DE19680170C2 (de) * 1995-02-10 2001-11-15 Enshu Co Sicherheitsgurtaufhängungs- und halteteil
CN1198100A (zh) * 1996-06-11 1998-11-04 佐纳根有限公司 聚氨基葡糖药物投递系统
AU5576498A (en) * 1997-02-05 1998-08-26 Sankyo Company Limited Prophylactic or therapeutic agent for diabetic complication
US8273866B2 (en) * 2002-02-20 2012-09-25 Merck Sharp & Dohme Corp. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
EP1262180A4 (de) 2000-02-18 2005-06-01 Takeda Pharmaceutical Tnf-alpha hemmer
US7087608B2 (en) 2000-03-03 2006-08-08 Robert Charles Atkins Use of PDGF receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
WO2004071534A1 (ja) * 2003-02-17 2004-08-26 Takeda Pharmaceutical Company Limited 腎疾患の予防・治療剤
US7021099B2 (en) * 2003-06-12 2006-04-04 General Motors Corporation Extraction system for hot formed parts
WO2005065680A1 (en) * 2003-12-19 2005-07-21 Merck & Co., Inc. Cyclic guanidines, compositions containing such compounds and methods of use
KR20070074576A (ko) 2004-10-29 2007-07-12 코와 가부시키가이샤 사구체 질환 치료제
TW200719896A (en) * 2005-04-18 2007-06-01 Astrazeneca Ab Combination product
AR057455A1 (es) 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
ES2743784T3 (es) * 2007-03-28 2020-02-20 Takeda Pharmaceuticals Co Composición farmacéutica sólida que comprende un derivado de benzimidazol-7-carboxilato y un agente regulador del pH
JP5559696B2 (ja) * 2008-10-22 2014-07-23 協和発酵キリン株式会社 糖尿病性腎症の治療剤
RU2635460C2 (ru) 2010-06-17 2017-11-13 Нитто Денко Корпорейшн Средство для лечения фиброза почек

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128256A (en) * 1987-01-12 1992-07-07 Stratagene DNA cloning vectors with in vivo excisable plasmids
DE3928177A1 (de) * 1989-04-08 1991-02-28 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0400835A1 (de) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituierte Benzimidazole als Angiotensin II-Hemmer
EP0411507B1 (de) * 1989-08-02 1994-10-26 Takeda Chemical Industries, Ltd. Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung
DE3927170A1 (de) * 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (de) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Kondensierte Imidazolderivate, ihre Herstellung und Verwendung
ATE169915T1 (de) * 1990-02-15 1998-09-15 Takeda Chemical Industries Ltd Pyrimidindionderivate, deren herstellung und verwendung
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
ES2121773T3 (es) * 1990-06-08 1998-12-16 Hoechst Marion Roussel Inc Derivados de bencimidazol, su procedimiento de preparacion, productos intermedios, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ATE146076T1 (de) * 1990-06-22 1996-12-15 Du Pont Behandlung des chronischen nierenversagens mit imidazol-angiotensin-ii-rezeptorantagonisten
AU8405691A (en) * 1990-09-04 1992-03-30 Yamanouchi Pharmaceutical Co., Ltd. Novel tetrahydrobenzazole derivative
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
GB9027210D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
TW274551B (de) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them
ATE167861T1 (de) * 1992-09-14 1998-07-15 Takeda Chemical Industries Ltd 1,2,4-oxadiazolyl oder 1,2,4-thiadiazolyl- derivate als angiotensin ii antagonisten
EP0603712B1 (de) * 1992-12-22 2001-08-16 Takeda Chemical Industries, Ltd. Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung
JP3810020B2 (ja) * 1993-04-22 2006-08-16 武田薬品工業株式会社 腎疾患の予防または治療剤

Also Published As

Publication number Publication date
JP3810020B2 (ja) 2006-08-16
BR1100756KB1 (pt) 2011-10-18
EP0622077A1 (de) 1994-11-02
DE69425085D1 (de) 2000-08-10
US20040082636A1 (en) 2004-04-29
US5719173A (en) 1998-02-17
CA2121871A1 (en) 1994-10-23
US6469037B2 (en) 2002-10-22
US7135490B2 (en) 2006-11-14
DK0622077T3 (da) 2000-10-23
ATE194284T1 (de) 2000-07-15
DE69425085T2 (de) 2000-11-09
GR3033862T3 (en) 2000-10-31
ES2149226T3 (es) 2000-11-01
US6319938B1 (en) 2001-11-20
US20030114509A1 (en) 2003-06-19
JPH072667A (ja) 1995-01-06
PT622077E (pt) 2000-10-31
CA2121871C (en) 2006-12-12
US6686383B2 (en) 2004-02-03
EP0622077B1 (de) 2000-07-05
US5889036A (en) 1999-03-30
US20020045652A1 (en) 2002-04-18
US6040324A (en) 2000-03-21

Similar Documents

Publication Publication Date Title
CY2204B1 (en) Angiotensin ii antagonists as a prophylactic or therapeutic drug for renal diseases
SG45336A1 (en) A pharmaceutical composition for angiotens ii-mediated diseases
DE69725978D1 (de) Chalcon-derivate und medikamente die diese enthalten
LV12209A (lv) Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori
MX9708781A (es) Heterociclos como inhibidores de la adhesion de leucocitos y antagonistas de vla-4.
ATE377602T1 (de) Morphinanderivate und ihre medizinische anwendung
DE69709493D1 (de) Substituierte Indazolderivate
AU8811401A (en) Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
EP1329218A4 (de) Wirkstoffe zur vorbeugung und behandlung portaler hypertonie
EP0546177A4 (de) Benzopyran derivat, seine darstellung und pharmazeutische zusammensetzung, welche dieses enthält.
MY129094A (en) Condensed polycyclic compounds
EP1354871A4 (de) Biphenylderivate
PL353863A1 (en) Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
FI933652A0 (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler